Filed 2.1y ago· May 2, 2024
22 days to disclose
Michael C. Burgess
—HouseTexas-26
↓sold
Merck
MRK
$1K-$15K
+50.6% vs S&P 500
Trade dateApr 10, 2024
Stock
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–8 of 8
Filed 2.1y ago· May 2, 2024
22 days to discloseMichael C. Burgess
—HouseTexas-26
↓sold
AbbVie
ABBV
$1K-$15K
+21.3% vs S&P 500
Trade dateApr 10, 2024
Filed 2.4y ago· Jan 22, 2024
20 days to discloseMichael C. Burgess
—HouseTexas-26
↓sold
Amgen
AMGN
$15K-$50K
+35.2% vs S&P 500
Trade dateJan 2, 2024
Filed 2.5y ago· Dec 18, 2023
10 days to discloseMichael C. Burgess
—HouseTexas-26
↓sold
AbbVie
ABBV
$1K-$15K
+22.0% vs S&P 500
Trade dateDec 8, 2023
Filed 2.7y ago· Oct 3, 2023
20 days to discloseMichael C. Burgess
—HouseTexas-26
↓sold
Merck
MRK
$1K-$15K
+11.8% vs S&P 500
Trade dateSep 13, 2023
Stock
Filed 2.7y ago· Sep 5, 2023
27 days to discloseMichael C. Burgess
—HouseTexas-26
↑bought
AbbVie
ABBV
$15K-$50K
−28.4% vs S&P 500
Trade dateAug 9, 2023
Filed 2.9y ago· Jul 18, 2023
12 days to discloseMichael C. Burgess
—HouseTexas-26
↑bought
AbbVie
ABBV
$15K-$50K
+43.3% vs S&P 500
Trade dateJul 6, 2023
Filed 3.1y ago· Apr 14, 2023
4 days to discloseMichael C. Burgess
—HouseTexas-26
↓sold
Amgen
AMGN
$15K-$50K
+37.0% vs S&P 500
Trade dateApr 10, 2023
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 2, 2024 2.1y ago | Michael C. Burgess —HouseTexas-26 | ↓sold | Merck MRK Stock | Apr 10, 2024 22 days to disclose | Smart sell·+$937+11.7% +50.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 2, 2024 2.1y ago | Michael C. Burgess —HouseTexas-26 | ↓sold | AbbVie ABBV | Apr 10, 2024 22 days to disclose | Missed gain·−$1.4K-17.6% +21.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 22, 2024 2.4y ago | Michael C. Burgess —HouseTexas-26 | ↓sold | Amgen AMGN | Jan 2, 2024 20 days to disclose | Missed gain·−$5.2K-15.9% +35.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Dec 18, 2023 2.5y ago | Michael C. Burgess —HouseTexas-26 | ↓sold | AbbVie ABBV | Dec 8, 2023 10 days to disclose | Missed gain·−$2.6K-33.1% +22.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 3, 2023 2.7y ago | Michael C. Burgess —HouseTexas-26 | ↓sold | Merck MRK Stock | Sep 13, 2023 20 days to disclose | Flat·+0.0% +11.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 5, 2023 2.7y ago | Michael C. Burgess —HouseTexas-26 | ↑bought | AbbVie ABBV | Aug 9, 2023 27 days to disclose | Good buy·+$10.3K+31.8% −28.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jul 18, 2023 2.9y ago | Michael C. Burgess —HouseTexas-26 | ↑bought | AbbVie ABBV | Jul 6, 2023 12 days to disclose | Good buy·+$18.6K+57.1% +43.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 14, 2023 3.1y ago | Michael C. Burgess —HouseTexas-26 | ↓sold | Amgen AMGN | Apr 10, 2023 4 days to disclose | Missed gain·−$12.1K-37.3% +37.0% vs S&P 500 | $15K-$50K midpoint $32.5K |